Product Pathways - Nuclear Receptor Signaling
Progesterone Receptor B (C1A2) Rabbit mAb #3157
|3157S||100 µl (10 western blots)||---||In Stock||---|
|3157||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IHC-P=Immunohistochemistry (Paraffin), IF-IC=Immunofluorescence (Immunocytochemistry), F=Flow Cytometry
Specificity / Sensitivity
Progesterone Receptor B (C1A2) Rabbit mAb detects endogenous levels of total progesterone receptor B protein. This antibody does not cross-react with other PR family members.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ser115 of human progesterone receptor.
Western blot analysis of extracts from MCF-7 and T47D cells using Progesterone Receptor B (C1A2) Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Progesterone Receptor B Receptor (C1A2) Rabbit mAb in the presence of control peptide (left) or antigen-specific peptide (right).
Flow cytometric analysis of T-47D cells using Progesterone Receptor B Receptor (C1A2) Rabbit mAb (blue) compared to a nonspecific negative control antibody (red).
Human progesterone receptor (PR) is expressed as two forms: the full length PR-B and the short form PR-A. PR-A lacks the first 164 amino acid residues of PR-B (1,2). Both PR-A and PR-B are ligand activated, but differ in their relative ability to activate target gene transcription (3,4). The activity of PR is regulated by phosphorylation; at least seven serine residues are phosphorylated in its amino-terminal domain. Three sites (Ser81, Ser102, and Ser162) are unique to full length PR-B, while other sites (Ser190, Ser294, Ser345, and Ser400) are shared by both isoforms (5). Phosphorylation of PR-B at Ser190 (equivalent to Ser26 of PR-A) is catalyzed by CDK2 (6). Mutation of Ser190 results in decreased activity of PR (7), suggesting that the phosphorylation at Ser190 may be critical to its biological function.
- Evans, R.M. (1988) Science 240, 889-895.
- Kastner, P. et al. (1990) EMBO J. 112, 1603-1614.
- Giangrande, P.H. et al. (2000) Mol. Cell. Biol. 20, 3102-3115.
- Wen, D.X. et al. (1994) Mol. Cell. Biol. 14, 8356-8364.
- Clemm, D.L. et al. (2000) Mol. Endocrinol. 14, 52-65.
- Zhang, Y. et al. (1997) Mol. Endocrinol. 11, 823-832.
- Takimoto, G.S. et al. (1996) J. Biol. Chem. 271, 13308-13316.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 3171 Phospho-Progesterone Receptor (Ser190) Antibody
- 3172 Progesterone Receptor (6A1) Mouse mAb
- 3176 Progesterone Receptor A/B Antibody
- 3178 Progesterone Receptor B Antibody
- 8112 SignalStain® Antibody Diluent
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 3153 Progesterone Receptor A/B (C89F7) Rabbit mAb
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
This antibody is developed, validated, and produced by CST using in part technology under license (granting certain rights including those under U.S. Patent No. 5,675,063) from Epitomics, Inc.